Jenny Kobin | Investor Relations |
George Lasezkay | Chief Executive Officer |
Dr. Thomas Ciulla | Chief Medical Officer and Chief Development Officer |
Charlie Deignan | Chief Financial Officer |
Annabel Samimy | Stifel |
Andreas Argyrides | Wedbush |
Zegbeh Jallah | ROTH Capital Partners |
Rohit Basin | Needham |
Jon Wolleben | JMP Securities |
Good day. Thank you for standing by. Welcome to the Clearside Biomedical Fourth Quarter 2021 Financial Results and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-Answer session.